Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Pitz

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2025
Secukinumab in Moderate-to-Severe Graves' Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter StudyJan Wolf, Katrin Lorenz, Ahmed E Othman, et al.
European Journal of Endocrinology|April 14, 2018
Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidismWilmar Wiersinga, Miloš Žarković, Luigi Bartalena, et al.
Orphanet Journal of Rare Diseases|November 9, 2011
Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare diseaseMaurizio Scarpa, Zsuzsanna Almássy, Michael Beck, et al.
European Journal of Endocrinology|February 27, 2008
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GOLuigi Bartalena, Lelio Baldeschi, Alison Dickinson, et al.
Thyroid : Official Journal of the American Thyroid Association|March 18, 2008
Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathyLuigi Bartalena, Lelio Baldeschi, Alison J Dickinson, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2023
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye DiseaseGeorge J Kahaly, Peter J Dolman, Jan Wolf, et al.
The British Journal of Ophthalmology|May 9, 2015
PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012Petros Perros, Miloš Žarković, Claudio Azzolini, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2025
Secukinumab in Moderate-to-Severe Graves' Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter StudyJan Wolf, Katrin Lorenz, Ahmed E Othman, et al.
European Journal of Endocrinology|April 14, 2018
Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidismWilmar Wiersinga, Miloš Žarković, Luigi Bartalena, et al.
Orphanet Journal of Rare Diseases|November 9, 2011
Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare diseaseMaurizio Scarpa, Zsuzsanna Almássy, Michael Beck, et al.
European Journal of Endocrinology|February 27, 2008
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GOLuigi Bartalena, Lelio Baldeschi, Alison Dickinson, et al.
Thyroid : Official Journal of the American Thyroid Association|March 18, 2008
Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathyLuigi Bartalena, Lelio Baldeschi, Alison J Dickinson, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2023
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye DiseaseGeorge J Kahaly, Peter J Dolman, Jan Wolf, et al.
The British Journal of Ophthalmology|May 9, 2015
PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012Petros Perros, Miloš Žarković, Claudio Azzolini, et al.
Pageof 9